As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma leaders aren’t looking to miss out on implementing the technology into t | Define Ventures’ report on the industry’s approach to AI found that 85% of Big Pharma leaders consider AI an “immediate priority,” with 85% planning to increase their AI budgets in turn.